The Efficacy of Early Postoperative Enteral Immunonutrition in Low-Risk Cardiac Surgery Patients
1 other identifier
interventional
55
1 country
1
Brief Summary
The aim of this study is to investigate the efficacy of early postoperative enteral immunonutrition on immune response and outcomes in the low operative risk cardiac surgery population with low phase angle value measured by the bioelectrical impedance analysis.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Feb 2015
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 1, 2015
CompletedFirst Submitted
Initial submission to the registry
July 22, 2019
CompletedFirst Posted
Study publicly available on registry
August 6, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
October 1, 2021
CompletedMarch 11, 2022
February 1, 2022
4.6 years
July 22, 2019
February 24, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (6)
CD4+ T cell
Blood samples were collected twice on the surgery and on the sixth postoperative day by sampling blood for CD4+ T cells.
Six days
CD8+ T cell
Blood samples were collected twice on the surgery and on the sixth postoperative day by sampling blood for CD8+ T cells.
Six days
CD69+ T cell
Blood samples were collected twice on the surgery and on the sixth postoperative day by sampling blood for CD69+ T cells.
Six days
Interleukin-1 (IL-1)
Blood samples were collected twice on the surgery and on the sixth postoperative day by sampling blood for IL-1.
Six days
Interleukin-6 (IL-6)
Blood samples were collected twice on the surgery and on the sixth postoperative day by sampling blood for IL-6.
Six days
Tumor necrosis factor alfa (TNFα)
Blood samples were collected twice on the surgery and on the sixth postoperative day by sampling blood for TNFα.
Six days
Secondary Outcomes (8)
Acute kidney injury
28 days
Stroke
28 days
ICU infectious complications
28 days
Duration of mechanical ventilation
28 days
Retoracotomy rate
28 days
- +3 more secondary outcomes
Study Arms (2)
Intervention
EXPERIMENTALNormal daily meals plus one sachet three times a day of immune nutrients for five days after the surgery. 8 a.m. - normal meal plus one sachet immune nutrients 1 p.m - normal meal plus one sachet immune nutrients 6 p.m. - normal meal plus one sachet immune nutrients
Control
ACTIVE COMPARATORNormal daily meals. 8 a.m. - normal meal 1 p.m. - normal meal 6 p.m. - normal meal
Interventions
"Glutamine Plus" by Fresenius Kabi (one sachet composition: glutamine 10 g, carbohydrate 10 g, β-carotene 1.7 mg, vitamin E 83 mg, vitamin C 250 mg, zinc 3.4 mg, selenium 50 μg, and fibre 1.2 g).
Eligibility Criteria
You may qualify if:
- Age ≥18 years;
- Elective cardiac surgery with cardiopulmonary bypass:
- coronary artery bypass grafting surgery (CABG);
- aortic valve replacement;
- mitral valve replacement;
- mitral valve repair;
- tricuspid valve repair;
- combined operations (CABG and valve surgery);
- Phase angle \<5.5⁰ (phase angle was evaluated one day prior to surgery using bioelectrical impedance analysis (InbodyS10 device).
You may not qualify if:
- Preoperative:
- previous cardiac surgery;
- left ventricle ejection fraction \<40%;
- use of preoperative intra-aortic balloon pump (IABP);
- critical preoperative state;
- pulmonary artery mean pressure \>55 mmHg;
- diagnosis of infectious endocarditis;
- pacemaker;
- Operative:
- complicated intraoperative course (unplanned intervention or low cardiac output syndrome in the operating theatre: failure to wean from cardiopulmonary bypass (CPB) or intraoperative insertion of IABP or infusion of two or more inotropic medications with a cumulative dose of 0.2 mcg/kg/min);
- surgery time \>6 h;
- unplanned intervention;
- Postoperative:
- disturbance of dietary rules.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Vilnius University Hospital Santaros klinikos
Vilnius, 08661, Lithuania
Related Publications (1)
Svetikiene M, Ringaitiene D, Vezeliene J, Isajevas V, Trybe D, Vicka V, Malickaite R, Jurgauskiene L, Norkuniene J, Serpytis M, Sipylaite J. The efficacy of early postoperative enteral immunonutrition on T-lymphocyte count: A randomised control study in low-risk cardiac surgery patients. Clin Nutr. 2021 Feb;40(2):372-379. doi: 10.1016/j.clnu.2020.05.009. Epub 2020 May 15.
PMID: 32513480DERIVED
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Jurate Sipylaite, MD, PhD
Vilnius University, Faculty of Medicine
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- PhD Vilnius University Institute of Clinical Medicine Clinic of Anaesthesiology and Intensive Care
Study Record Dates
First Submitted
July 22, 2019
First Posted
August 6, 2019
Study Start
February 1, 2015
Primary Completion
September 1, 2019
Study Completion
October 1, 2021
Last Updated
March 11, 2022
Record last verified: 2022-02
Data Sharing
- IPD Sharing
- Will not share